WAIRIMU MWAURA: Open Payments
NPI 1598320996 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,709 in 118 payments from 39 companies in 2025. Trend: 2023 $2,495 · 2024 $2,031 · 2025 $3,709
Food & beverage: $3,341Education: $368
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $616 |
| AstraZeneca Pharmaceuticals LP | 17 | $615 |
| Celgene Corporation | 11 | $198 |
| Incyte Corporation | 4 | $170 |
| ABBVIE INC. | 8 | $162 |
| Eisai Inc. | 2 | $148 |
| Merck Sharp & Dohme LLC | 5 | $148 |
| Gilead Sciences, Inc. | 1 | $119 |
| PFIZER INC. | 5 | $106 |
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
Products named: TECVAYLI, DARZALEX, RYBREVANT, Lenvima, KEYTRUDA, BREYANZI, IMFINZI, FOTIVDA.
Industry payments across CA — which companies pay providers there.
